Moderna mRNA流感疫苗获FDA顾问支持
2026-06-18 18:55:03
Moderna Inc.采用mRNA技术的流感疫苗获美国食品药品监督管理局(FDA)外部顾问建议批准。 据 Bloomberg 报道，这对该机构内一直存在争议的产品而言是积极进展。
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
Previous article：
Peter Schiff抨击Strategy优先股STRC大跌Next article：
高盛：2026年铝市或缺口72万吨
